Adjunctive intracoronary thrombolysis in complicated coronary angioplasty

Annals of Pharmacotherapy

Volumn 31, Issue 10, 1997, Pages 1244-1246

  Crouch, Michael A ^a   Nappi, Jean M ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; STREPTOKINASE; UROKINASE;

BLOOD CLOT LYSIS; CLINICAL TRIAL; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; DRUG CONTRAINDICATION; DRUG COST; DRUG EFFICACY; FIBRINOLYTIC THERAPY; HUMAN; INTRACORONARY INFUSION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY DISEASE; HUMANS; MYOCARDIAL ISCHEMIA; STREPTOKINASE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 0030885208     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. de Feyter PJ, de Jaegere PT, Serruys PW. Incidence, predictors, and management of acute coronary occlusion after coronary angioplasty. Am Heart J 1994;127:643-51.
2. Vaitkus PT, Laskey WK. Efficacy of adjunctive thrombolytic therapy in percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1994;24:1415-23.
3. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996;335:217-25.
4. Ambrose JA. Thrombolysis as an adjunct to angioplasty. Am J Cardiol 1993;72:34G-39G.
5. Neuhaus KL, Zeymer U. Prevention and management of thrombotic complications during coronary interventions. Combination therapy with antithrombins, and antiplatelets, and/or thrombolytics: risks and benefits. Eur Heart J 1995;16:63-7.
6. Ambrose JA, Almeida OD, Sharma SK, Torre SR, Marmur JD, Israel DH, et al. Adjunctive thrombolytic therapy during angioplasty for ischemic rest angina: results of the TAUSA Trial. Circulation 1994;90:69-77.
7. Schachinger V, Kasper W, Zeiher AM. Adjunctive intracoronary urokinase therapy during percutaneous transluminal coronary angioplasty. Am J Cardiol 1996;77:1174-8.
8. Schofer J, Krebber HJ, Bleifeld W, Mathey DG. Acute coronary artery occlusion during percutaneous transluminal coronary angioplasty: re-opening by intracoronary streptokinase before emergency coronary artery surgery to prevent myocardial infarction. Circulation 1982;66: 1325-31.
9. Suryapranata H, de Feyter PJ, Serruys PW. Coronary angioplasty in patients with unstable angina pectoris: is there a role for thrombolysis? J Am Coll Cardiol 1988;12:69A-77A.
10. de Feyter PJ, van den Brand M, Jaarman GJ, van Domburg R, Serruys PW, Suryapranata H, et al. Acute coronary artery occlusion during and after percutaneous coronary angioplasty: frequency, prediction, clinical course, management, and follow-up. Circulation 1991;83:927-36.
11. Gulba DC, Daniel WG, Simon R, Jost S, Barthels M, Amende I, et al. Role of thrombolysis and thrombin in patients with acute coronary occlusion during percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1990;16:563-8.
12. Clinical experience with intracoronary tissue plasminogen activator: results of a multicenter registry: intracoronary t-PA registry investigators. Cathet Cardiovasc Diagn 1995;34:196-201.
13. Goudreau E, DiSciascio G, Vetrovec GW, Chami Y, Kohli R, Warner M, et al. Intracoronary urokinase as an adjunct to percutaneous transluminal coronary angioplasty in patients with complex coronary narrowing or angioplasty induced complications. Am J Cardiol 1992;69:57-62.
14. Vema E, Repetto S, Boscarini M, Onofri M, Qing LG, Binaghi G. Management of complicated coronary angioplasty by intracoronary urokinase and immediate re-angioplasty. Cathet Cardiovasc Diagn 1990;19: 116-22.
15. Schieman G, Cohen BM, Kozina J, Erickson JS, Podolin RA, Peterson KL, et al. Intracoronary urokinase for intracoronary thrombus accumulation complicating percutaneous transluminal coronary angioplasty in acute ischemic syndromes. Circulation 1990;82:2052-60.
16. Vaitkus PT, Herrmann HC, Laskey WK. Management and immediate outcome of patients with intracoronary thrombus during percutaneous transluminal coronary angioplasty. Am Heart J 1992;124:1-7.
17. Lincoff AM, Popma JJ, Ellis SG, Hacker JA, Topol EJ. Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile. J Am Coll Cardiol 1992;19:926-35.
18. Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high risk coronary angioplasty. N Engl J Med 1994;330:956-61.
19. Topol EJ, Califf RM, Weisman JF, Ellis SG, Tcheng JE, Worley S, et al. Randomized trial of coronary intervention with antibody against platelet II/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet 1994;343:881-6.
20. Anderson VH, Revana M, Rosales O, Brannigan L, Stuart Y, Weisman H, et al. Intravenous administration of monoclonal antibody to the platelet GP IIb/IIIa receptor to treat abrupt closure during coronary angioplasty. Am J Cardiol 1992;69:1373-6.
21. Cardinale V, Chi JC, eds. Drug topics red book. Montvale, NJ: Medical Economics Co., Inc., 1997.